Class / Patent application number | Description | Number of patent applications / Date published |
424699000 | Carbon disulfide, monoxide, or dioxide | 32 |
20080206362 | DEVICE AND METHOD FOR INCREASING BLOOD FLOW AND INSULIN-LIKE GROWTH FACTOR - In order to provide a device and a method for increasing blood flow and an insulin-like growth factor with use of a large amount of carbonic gas nano bubbles, the device of the present invention includes: a bathtub | 08-28-2008 |
20090011051 | Methods, Compositions and Articles of Manufacture for HIF Modulating Compounds - The present invention generally relates to the modulation of hypoxia-inducible factor (HIF) using the compounds and methods disclosed herein. These compounds and methods can be applied to the prevention, pretreatment, and/or treatment of conditions or states associated with HIF, such as hypoxia- and ischemia-related conditions and the induction of stasis. | 01-08-2009 |
20090117207 | Methods and compositions for treatment of poison-caused pathology - A method of treating a poison-caused pathology in an individual subject is described which includes administering a pharmaceutical composition including a therapeutically effective amount of a chloride current modulator, a therapeutically effective amount of an exogenous oxygen carrier, or a combination of a therapeutically effective amount of a chloride current modulator and a therapeutically effective amount of an exogenous oxygen carrier, to an individual subject exposed to a poison. Optionally, an inventive method further includes administering a therapeutic agent to inhibit poison-caused pathology. A composition according to the invention is described which includes a therapeutically effective amount of a chloride current modulator, a therapeutically effective amount of an exogenous oxygen carrier, or a combination of a therapeutically effective amount of a chloride current modulator and a therapeutically effective amount of an exogenous oxygen carrier. Further included in one embodiment is a therapeutic agent to inhibit poison-caused pathology. | 05-07-2009 |
20100196516 | TREATMENT OF INFECTIONS BY CARBON MONOXIDE - The invention relates to the use of carbon monoxide (CO) to treat infections. The invention also provides novel carbon monoxide releasing molecules (CORMs). | 08-05-2010 |
20100239691 | MODULATING LATENCY AND REACTIVATION OF MYCOBACTERIUM TUBERCULOSIS - Methods for screening for agents that modulate the activation state, i.e., active growth or persistence, of | 09-23-2010 |
20110038955 | PREVENTION OF GASTRIC ULCER BY CARBON MONOXIDE - The invention relates to the use of carbon monoxide (CO) to inhibit the gastrointestinal side effects caused by non-steroidal anti-inflammatory drugs (NSAIDs) and/or alcohol. | 02-17-2011 |
20110280966 | DOSING REGIMENS AND METHODS OF TREATMENT USING CARBON MONOXIDE - The present invention is directed to dosing regimens for the administration of carbon monoxide in the treatment of various indications as well as methods for enhancing organ function following transplant thereof. | 11-17-2011 |
20120276220 | Method of Treating Hepatitis - The present invention relates to a method of treating hepatitis in a patient, which includes administering a pharmaceutical composition that includes carbon monoxide to the patient. | 11-01-2012 |
20120282353 | METHODS, COMPOSITIONS AND ARTICLES OF MANUFACTURE FOR HIF MODULATING COMPOUNDS - The present invention generally relates to the modulation of hypoxia-inducible factor (HIF) using the compounds and methods disclosed herein. These compounds and methods can be applied to the prevention, pretreatment, and/or treatment of conditions or states associated with HIF, such as hypoxia- and ischemia-related conditions and the induction of stasis. | 11-08-2012 |
20130202720 | METHODS OF TREATING HEPATITIS - The present invention relates to a method of treating hepatitis in a patient, which includes administering a pharmaceutical composition that includes carbon monoxide to the patient. | 08-08-2013 |
20140113008 | ASSESSMENT OF IRON DEPOSITION POST MYOCARDIAL INFARCTION AS A MARKER OF MYOCARDIAL HEMORRHAGE - The invention is directed to methods for diagnosing reperfusion/non-reperfusion hemorrhage and predicting cardiac arrhythmias and sudden cardiac death in subjects comprising using imaging techniques to detect regional iron oxide deposition. The invention also provides treatment methods for subject at increased risk of sudden cardiac death. | 04-24-2014 |
20140141103 | METHODS OF TREATING HEPATITIS - The present invention relates to a method of treating hepatitis in a patient, which includes administering a pharmaceutical composition that includes carbon monoxide to the patient. | 05-22-2014 |
20140212514 | PREVENTION OF GASTRIC ULCER BY CARBON MONOXIDE - The invention relates to the use of carbon monoxide (CO) to inhibit the gastrointestinal side effects caused by non-steroidal anti-inflammatory drugs (NSAIDs) and/or alcohol. | 07-31-2014 |
20140287066 | DOSING REGIMENS AND METHODS OF TREATMENT USING CARBON MONOXIDE - The present invention is directed to dosing regimens for the administration of carbon monoxide in the treatment of various indications as well as methods for enhancing organ function following transplant thereof. | 09-25-2014 |
20140314879 | TREATMENT OF COMPARTMENT SYNDROME - The present invention relates to a method of treating or preventing compartment syndrome in a patient. According to the invention, the method includes: (a) identifying a patient suffering from compartment syndrome; and (b) administering to the patient a therapeutically effective amount of a carbon monoxide (CO). | 10-23-2014 |
424700000 | Carbon dioxide | 17 |
20080213402 | Composition For Preparing Carbon Dioxide External Preparation - The invention is directed to a composition for preparing a carbon dioxide external preparation characterized by comprising a substance generating an acid after being hydrolyzed, a carbonate, a thickener and water as essential components, and a composition for preparing a carbon dioxide external preparation characterized by comprising the essential components above, a gelating agent being gelated by a calcium ion and a water-insoluble or poorly soluble calcium salt. According to the invention, the carbon dioxide external preparation, which contains sufficient amount of carbon dioxide, from which the carbon dioxide is absorbed transdermally or transmucosally in a sustained manner, and which has a more potent cosmetic or medical effect, can be easily prepared. In addition, the composition for preparing a carbon dioxide external preparation with a low cost can be provided. | 09-04-2008 |
20090202661 | BEVERAGE MANUFACTURE, PROCESSING, PACKAGING AND DISPENSING USING ELECTROCHEMICALLY ACTIVATED WATER - A system using electrochemically-activated water (ECAW) for manufacturing, processing, packaging, and dispensing beverages including: (a) using ECAW to neutralize incompatible residues when transitioning from the production of one beverage to another; (b) using ECAW to rehabilitate and disinfect granular activated charcoal beds used in the feed water purification system; (c) producing a carbonated ECAW product and using the carbonated ECAW for system cleaning or disinfecting; (d) using ECAW solutions in the beverage facility clean-in-place system to achieve improved microbial control while greatly reducing water usage and reducing or eliminating the use of chemical detergents and disinfectants; (e) further reducing biofilm growth in the processing system, and purifying ingredient water without the use of chlorine, by adding an ECAW anolyte to the water ingredient feed stream; and/or (f) washing the beverage product bottles or other packages with one or more ECAW solutions prior to packaging. | 08-13-2009 |
20090291150 | METHOD AND COMPOSITIONS FOR TREATING AND PREVENTING SEIZURES BY MODULATING ACID-SENSING ION CHANNEL ACTIVITY - This invention provides novel methods and compositions for treating and preventing seizures by administration of ASIC1a receptor activating compounds. A novel method of assaying ASIC1a receptor activating compounds is included in the present invention. According to the invention applicants have demonstrated that seizure duration, intensity, and progression may be modulated by administration of an ASIC1a receptor activator which acts to increase the endogenous activity of ASIC1a receptors to mediate the effects of low pH in the CNS. The inventors have also found that the ASIC1a receptor activator may prevent such seizures altogether. | 11-26-2009 |
20090297633 | PROCESS FOR PRODUCING SOLUTION HAVING CARBON DIOXIDE DISSOLVED THEREIN, APPARATUS THEREFOR AND CARBONATED WATER - The oxalic acid aqueous solution filled in an electrolytic tank is electrolyzed with an electrolyzer to produce carbonic acid gas, while ultrasonic wave from an ultrasonic generator is applied to the produced carbonic acid gas bubbles, to form micro bubbles, which is dissolved in said oxalic acid aqueous solution, so as to easily produce carbonic acid gas solution with micro carbonic acid gas bubbles dissolved at a low cost; said carbonic acid gas solution can substitute carbonated spring. | 12-03-2009 |
20100104665 | Methods and Apparatus for Treating Rhinitis - Apparatus and methods deliver treatment agents simultaneously with capnic gases. The capnic gases can enhance the effectiveness of the treatment agent for treating rhinitis, lower the dosage of drug or concentration of agent necessary to achieve a therapeutic result, or both. Exemplary capnic gases include carbon dioxide, nitric oxide, nitrous oxide, and dilute acid gases. | 04-29-2010 |
20100112093 | Compositions and methods for therapeutic delivery with frozen particles - Certain embodiments disclosed herein relate to compositions, methods, devices, systems, and products regarding frozen particles. In certain embodiments, the frozen particles include materials at low temperatures. In certain embodiments, the frozen particles provide vehicles for delivery of particular agents. In certain embodiments, the frozen particles are administered to at least one biological tissue. | 05-06-2010 |
20100203171 | Therapeutic Foam - A therapeutic foam for the treatment of, inter alia, varicose veins comprises a sclerosing solution foamed with a physiological gas such as carbon dioxide, oxygen or a mixture thereof. The foam has a nitrogen content of less than 0.8%. It may be generated using a pressurised canister system incorporating a fine mesh of micron dimensions through which the gas and sclerosing liquid are passed to make the foam. Alternatively, the foam may be generated by passing gas and solution between two syringes through a fine mesh. Techniques are described for minimising the amount of nitrogen in a canister or syringe based product. A technique for generating and delivering foam simultaneously using a syringe based device is also disclosed. | 08-12-2010 |
20100247678 | USE OF CARBON DIOXIDE SUPPLYING MEANS FOR MUSCLE STRENGTHENING AND METHOD OF INCREASING CATTLE MEAT THEREBY - Use of a carbon dioxide-supplying means for muscle strengthening makes it possible conveniently to strengthen a target muscle within a short period of time merely by allowing the target site to absorb carbon dioxide without loading any mechanical burden on the target muscle. By loading a mechanical burden on the target muscle, the muscle strengthening effect can be further enhanced and an additional effect of promoting the recovery from muscle fatigue can be achieved owing to the mechanical burden. By using the carbon dioxide-supplying means for muscle strengthening as described above, it is also possible to increase cattle meat. | 09-30-2010 |
20110027392 | Peracetic Acid in an Anhydrous Sterilant Delivery System - Method and system for forming an anhydrous sterilant. In one embodiment, anhydrous peracetic acid is combined with carbon dioxide, wherein the carbon dioxide is in one of a liquid, solid, and supercritical state. | 02-03-2011 |
20110076346 | Novel compositions from Nigella sativa - Described are four, novel supercritical fluid extracts of | 03-31-2011 |
20120093946 | USE OF CARBON DIOXIDE SUPPLYING MEANS FOR MUSCLE STRENGTHENING AND METHOD OF INCREASING CATTLE MEAT THEREBY - Use of a carbon dioxide-supplying means for muscle strengthening makes it possible conveniently to strengthen a target muscle within a short period of time merely by allowing the target site to absorb carbon dioxide without loading any mechanical burden on the target muscle. By loading a mechanical burden on the target muscle, the muscle strengthening effect can be further enhanced and an additional effect of promoting the recovery from muscle fatigue can be achieved owing to the mechanical burden. By using the carbon dioxide-supplying means for muscle strengthening as described above, it is also possible to increase cattle meat. | 04-19-2012 |
20130280348 | Carbon dioxide and saline nasal delivery methods and treatments - Methods for treating ailments in a patient in need thereof includes the step of directing a therapeutic, non-inhaled dosage to at least one nasal cavity of the patient through a flow regulating device while the patient refrains from inhaling. The dosage includes a saline fluid and a gas containing carbon dioxide, wherein the therapeutic, non-inhaled dosage is delivered at a flow rate from 1 cc/sec to 20 cc/sec for a duration of 2 to 30 seconds. | 10-24-2013 |
20130302445 | APPARATUS AND METHOD FOR TREATING CEREBRAL ISCHEMIA USING NON-INHALED CARBON DIOXIDE - A non-invasive method of treating cerebral ischemia, involving the use of non-inhaled, intra-nasally delivered carbon dioxide (CO2), alone or in combination with other gases to augment cerebral perfusion and improve outcome following a stroke is provided. A vasodilator gas is delivered intranasally, alone or in combination with a second gas, for prolonged periods of time without systemic absorption. The second gas may be selected from NO, hydrogen, xenon, anesthetic gases, oxygen, nitrogen, nitrous oxide, carbon monoxide, or air. The treatment selectively increases cerebral perfusion and provides neuroprotection in the treatment of cerebral ischemia. | 11-14-2013 |
20130316021 | TREATMENT OF RESPIRATORY DISEASES - A method for treating a mammal suffering from a respiratory disease characterized by acute intermittent or chronic obstruction of the airways of the lungs, such as asthma, acute asthma, chronic obstructive pulmonary disease (COPD) and bronchiectasis comprising delivering to the lungs of the mammal a perfluorocarbon and a gas mixture comprising carbon dioxide (CO | 11-28-2013 |
20140044805 | METHOD OF PRODUCING SUBSTANCES WITH SUPERSATURATED GAS, TRANSDERMAL DELIVERY DEVICE THEREOF, AND USES THEREOF - The present specification disclosed a noninvasive transdermal delivery device that relates generally to a handheld mechanical apparatus for noninvasive transdermal administration of gas, small to large water-soluble (hydrophilic) pharmaceutical agents, vitamins, and other therapeutic agents. Components of such delivery devices, methods of producing a substance comprising a supersaturated amount of a dissolved gas, as well as, methods of administering a therapeutic agent using such delivery devices and methods of treating a disease or condition using such delivery devices are also disclosed. | 02-13-2014 |
20140322360 | METHOD AND DEVICE FOR ATTRACTING BLOOD-SUCKING ARTHROPODS - The invention relates to a method for producing CO2 for attracting bloodsucking arthropods ( | 10-30-2014 |
20160166605 | THERAPEUTIC AGENT FOR A DISEASE ACCOMPANIED BY EPILEPTIFORM DISCHARGES | 06-16-2016 |